Go Ad-Free
    My Alerts
    VICTORIS
    Budget Express 2026

    co-presented by

    • LIC
    • JIO BlackRock

    ASSOCIATE SPONSORS

    • Sunteck
    • SBI
    • Emirates
    • Dezerv
    Parallel Income Plan 2026
    Parallel Income Plan 2026

    Nectar Lifesciences manufacturing unit gets US FDA nod

    Nectar Lifesciences has received US Food and Drugs Administration (FDA) approval for its Active Pharmaceutical Ingredients (API) manufacturing plant Unit-II in Dera Bassi, Punjab.

    September 08, 2011 / 15:47 IST

    Moneycontrol Bureau

    Nectar Lifesciences has received US Food and Drugs Administration (FDA) approval for its Active Pharmaceutical Ingredients (API) manufacturing plant Unit-II in Dera Bassi, Punjab.

    Nectar Lifesciences hit the 20% upper circuit at Rs 23 on NSE post the announcement in afternoon trade.

    This facility has also been approved by Japan

    first published: Sep 8, 2011 02:41 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
    CloseParallel Income Plan 2026